Where does THE Doshisha rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), THE Doshisha ranks #7,088 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does THE Doshisha hold?

THE Doshisha holds 47 US utility patents granted between 2015 and 2025, spanning 54 technology areas.

What is THE Doshisha's Innovation Score?

THE Doshisha has an Innovation Score of 55.6 out of 100 (top 7% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does THE Doshisha focus on?

THE Doshisha's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 18 patents, ranking #1,084 of 6,058 assignees active in that subclass. Grants appear in 54 CPC subclasses total.

Is THE Doshisha's patent grant rate increasing or decreasing?

THE Doshisha's recent grant velocity is +59% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for THE Doshisha's patents?

THE Doshisha's patents average 11.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the THE Doshisha patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

THE Doshisha

USPTO PatentsView assignee record - 47 granted patents across 54 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, THE ranks #7,088 of 49,997 tracked US assignees by granted-patent volume, with 47 patents across 54 technology areas.

#7,088
of 49,997 US assignees by volume: Top 7%
by Innovation Score (55.6/100): 11.1
avg claims per patent: +59%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R7088 · Foreign Corporation #7,088 · 47 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-WIDE · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 47 grants
UPPER-Q #7,088/49,997
PHOTO-FINISH Sanford-Burnham…
CPC-WIDE A61P · 54 areas
INNOV-PAR 55.6/100
CLAIMS-PAR 11.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +59% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Sanford-Burnham Medical Research Institute (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How THE’s 55.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.4 pts (24%) Velocity 10.6 pts (19%) Breadth 25.0 pts (45%) Claim depth 6.7 pts (12%)

Qualcomm Incorporated · highest

85
Deutsches Zentrum… · near

56
THE Doshisha · this assignee

56
Auctane · near

56
JGC · near

56
United Kingdom… · near

56
3D Lighting… · lowest

7

What this shows THE's Innovation Score is 55.6/100 (top 7% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for THE?

Each dot is one of THE’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). THE’s own 11.1 claims/patent is at or below the 15.0 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

THE vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

How THE's grant cadence moved

Between 2020–2024, THE Doshisha received 27 grants versus 17 in 2015–2019 (+59% equal-window velocity, above median growth). Across complete PatentsView years, output peaked in 2022 at 8 grants and bottomed in 2016 at 2. Lead class A61P accounts for 38.3% of the portfolio across 54 subclasses. Volume neighbours: Sanford-Burnham Medical Research Institute (#7,081) and Techtronic Power Tools Technology Limited (#7,089).

THE's three-year grant acceleration

THE Doshisha shows 19 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Sanford-burnham M…

47
Sub-zero Group

47
Sulzer Chemtech

47
Supernus Pharmace…

47
Toyo Denso

47
Trinity Industrial

47
TRW Airbag Systems

47
Techtronic Power…

47
THE Doshisha ◀

47

What this shows THE holds 47 patents at rank #7,085, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near THE

By rank, the assignees closest to #7,085 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in THE's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for THE, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), THE ranks #1,084 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (56 here).

Deutsches Zentrum FÜR LUFT—UND Raumfahrt E.V. 56 JGC Corporation 56 Auctane, Inc. 56 United Kingdom Research and Innovation 56

THE's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

THE Doshisha patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	5	10.6%
2016	2	4.3%
2017	4	8.5%
2018	2	4.3%
2019	4	8.5%
2020	4	8.5%
2021	4	8.5%
2022	8	17.0%
2023	8	17.0%
2024	3	6.4%
2025partial year	3	6.4%

Which technologies does THE Doshisha patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 18

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 18

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 6

H01M - Processes OR Means, e.g. Batteries, FOR THE Direct Conversion OF Chemical Energy Into Electrical Energy 5

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 4

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 3

C07K - Peptides 3

H05B - Electric HEATING; Electric Light Sources NOT Otherwise Provided FOR; Circuit Arrangements FOR Electric Light Sources, IN General 3

Y02E - Reduction OF Greenhouse GAS [GHG] Emissions, Related TO Energy Generation, Transmission OR Distribution 3

C25D - Processes FOR THE Electrolytic OR Electrophoretic Production OF COATINGS; ELECTROFORMING; Apparatus Therefor 2

C25B - Electrolytic OR Electrophoretic Processes FOR THE Production OF Compounds OR NON-METALS; Apparatus Therefor 2

H04B - Transmission 2

Y02T - Climate Change Mitigation Technologies Related TO Transportation 2

F01N - Gas-flow Silencers OR Exhaust Apparatus FOR Machines OR Engines IN GENERAL; Gas-flow Silencers OR Exhaust Apparatus FOR Internal-combustion Engines 2

B29C - Shaping OR Joining OF PLASTICS; Shaping OF Material IN A Plastic State, NOT Otherwise Provided FOR; After-treatment OF THE Shaped Products, e.g. Repairing 2

Top 15 of 54 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

THE Doshisha's patent record in context - here's where to go next.

THE Doshisha's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 38.3% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #7,088 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare THE Doshisha against Sanford-Burnham Medical Research Institute, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 55.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.